Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
Open Access
- 1 November 2017
- journal article
- practice guideline
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 32 (6), 967-973
- https://doi.org/10.3904/kjim.2017.314
Abstract
The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.Funding Information
- Korean Diabetes Association
This publication has 39 references indexed in Scilit:
- Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes AssociationDiabetes & Metabolism Journal, 2017
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2014
- Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 DiabetesDiabetes Care, 2014
- Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 DiabetesDiabetes Care, 2013
- Safety and Efficacy of Modern Insulin AnaloguesDiabetes & Metabolism Journal, 2013
- Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulinDiabetes, Obesity and Metabolism, 2012
- Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failureInternational Journal of Clinical Practice, 2011
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 DiabetesThe New England Journal of Medicine, 2009
- Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial InfarctionCirculation, 1999
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995